Wingspan One Year Vascular Imaging Events and Neurologic Outcomes (NCT04221984) | Clinical Trial Compass
CompletedNot Applicable
Wingspan One Year Vascular Imaging Events and Neurologic Outcomes
United States129 participantsStarted 2019-11-12
Plain-language summary
The purpose of the study is to determine the one-year post stenting outcomes in patients who were treated with the Wingspan stent on-label in the WEAVE trial. This includes both the assessment of any stroke, hemorrhage, or death, as well as assessment of delayed imaging results to determine the re-stenosis rate of the stents in these patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Inclusion criteria for this study are the 152 patients stented in the WEAVE trial on-label.
The patients had the following inclusion criteria:
* Age 18-80
* Intracranial artery stenosis greater or equal to 70% stenosis
* Target artery 2 mm or larger
* Presented with stroke while on medical therapy for stroke prevention
* Prior stroke in the target territory
* Modified Rankin Score of 3 or better (neurologic function)
* Treated greater than 7 days after their last stroke
* Treated with the Wingspan stent by an approved trial NeuroInterventionalist
Exclusion Criteria:
* Patients treated outside of the trial or who did not meet the entry criteria.
* Patients that had stent treatment for arterial dissection
* Patients that had extra-cranial stenosis
* Patients outside the age range of the study
* Patients treated less than 8 days from their stroke.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
1-year stroke rate following placement of Wingspan stent in this patient cohort
Timeframe: 1 year
2
1-year death rate following placement of Wingspan stent in this patient cohort